Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering

Background:

• Drug-eluting stents (DES) are standard in percutaneous coronary revascularization, outperforming balloon angioplasty and bare metal stents.
• Continuous innovation in DES design aims to enhance efficacy and patient safety.

Purpose of the Study:

• To review the components of drug-eluting stents.
• To highlight design evolution in DES and its impact on clinical outcomes.

Main Methods:

• Review of contemporary drug-eluting stent designs.
• Analysis of advancements in stent materials and elution profiles.

Main Results:

• Current DES predominantly feature thin struts and durable polymers, eluting everolimus or zotarolimus.
• Novel DES with bioresorbable polymers and ultrathin struts demonstrate promising safety and efficacy.
• Thirty years of stent design evolution address limitations of earlier models to improve patient results.

Conclusions:

• Drug-eluting stents are crucial for managing obstructive coronary artery disease.
• Ongoing advancements in DES technology are vital for optimizing patient care and outcomes.